Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. - Wikidata - awgldk - TriplyDB

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

http://www.wikidata.org/entity/Q34073325

about

Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder Lurasidone for the treatment of irritability and anger in autism spectrum disorders.Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.Prenatal exposure to TAK242 affects the childhood autism in offspring in animal models of autism spectrum disorder.Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway.

P2860

Q35719523-119F52E4-9557-4876-8441-2187CEE395DE Q38017121-F42D5E78-D3BC-4CEF-AC5F-C60619806842 Q38689883-331C740D-78FB-42F2-93ED-8FE4C79AFA0D Q39384617-A2C93B2A-96C8-44A8-A575-ADBC772633C2 Q46154692-0F25E2F0-58A6-4F83-AF52-0857790AFFD1 Q54201255-D213C039-F864-4EB8-ACBC-25CC259246A7

P2860

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

http://www.wikidata.org/entity/Q34073325

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@ast

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@en

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@nl

type

label

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@ast

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@en

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@nl

prefLabel

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@ast

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@en

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@nl

P1433

Q34073325-9CAC2542-7603-4B57-9EDF-66E14F856653

P1476

Q34073325-698ED360-700E-48F8-B04A-37837E7AE891

P2093

Q34073325-18FE67BD-B276-472C-AF8B-A4A47DAC9211

Q34073325-38681403-DEA6-4393-9CC4-2D6C6BE788C2

Q34073325-3BEAB3FE-1A0B-415B-AD74-CC0C0020EDCF

Q34073325-868524A9-A3DE-4E46-9C3E-5D879ED281C9

P2860

Q34073325-03E32399-1761-4776-BA6D-AB02DDB8EB84

Q34073325-0711558D-8BFC-432D-9D13-E99F7D6E25B3

Q34073325-09A11FA2-6975-4368-980E-0447CC96EF3B

Q34073325-0D82CEA4-6150-40E4-8DD0-3CAA73046BD9

Q34073325-0EBA1F57-6DB1-4A95-A81E-8A110A57A5B7

Q34073325-0F77747C-E282-40B8-9CF9-34926F4F24A7

Q34073325-104236F8-038F-44B6-AD04-30FDFCC11B88

Q34073325-12E3B6AC-A033-4DEA-8ED0-C853DB613C41

Q34073325-13C438FC-A59B-4EEA-A4CB-8B7C693BD21F

Q34073325-18BE7C62-9115-42AD-A5DA-9647EECD123D

P304

Q34073325-60C4D828-D0B2-430D-89FE-CBE14997DD70

P31

Q34073325-66710134-EADF-4E0B-AFD3-CB1DB42DA3FD

P356

Q34073325-6EBF96CA-81BD-45D5-BD30-604F1F925AA7

P407

Q34073325-687133A0-D31C-4240-B9CD-696354FDE7BB

P433

Q34073325-C5D91F96-7E34-456E-B8B5-123A4ED01DA1

P478

Q34073325-A25730DD-6970-458D-8C32-40382A999A76

P50

Q34073325-4026896D-5561-426B-86C4-602875961EE1

P577

Q34073325-87B263D8-9CE4-44A4-9B4E-E8052A963869

P5875

Q34073325-00C27FEA-44FE-4AD3-946C-ABB3E0D6AA00

P698

Q34073325-3DD68E56-BC53-486D-8CEE-96DAE53349C9

P921

Q34073325-5495E123-E5AC-46E3-8BF0-9BB37BB7091F

Q34073325-B92CC27E-5A60-4D3B-847C-6F6CEDA2A61C

P932

Q34073325-30F24861-2AB7-4D0C-A979-8869C5D02C34

P356

14728214.2010.487860

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

@en

P2093

Craig A Erickson

http://www.w3.org/2001/XMLSchema#string

Kimberly A Stigler

http://www.w3.org/2001/XMLSchema#string

Logan K Wink

http://www.w3.org/2001/XMLSchema#string

Martin H Plawecki

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of pioglitazone treatment on behavioral symptoms in autistic children

Systematic Review of Early Intensive Behavioral Interventions for Children With Autism

Antipsychotics in the treatment of autism

Intravenous secretin for autism spectrum disorder

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism

Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study

Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

A retrospective study of memantine in children and adolescents with pervasive developmental disorders

P304

481-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2010.487860

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J McDougle

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44599456

http://www.w3.org/2001/XMLSchema#string

P698

20470188

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

2923687

http://www.w3.org/2001/XMLSchema#string